Hämophiliezentrum Med. Klinik III/Institut für Transfusionsmedizin

Frankfurt/M. 60590

1 studies enrolling now · 2 studies all time

What they study most

Von Willebrand Disease, Type 3

Studies at this site

• A Study to Assess the Efficacy and Safety of Emicizumab in Participants With Type 3 Von Willebrand Disease — Recruiting now
• An Observational Study of Participants With Type 3 Von Willebrand Disease on Prophylactic Standard-of-Care Treatment — Running, not enrolling